Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Fresenius SE KGaA's share price for the quarter that ended in Dec. 2023 was $7.725. Fresenius SE KGaA's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2,253 Mil. Therefore, Fresenius SE KGaA's market cap for the quarter that ended in Dec. 2023 was $17,404 Mil.
Fresenius SE KGaA's quarterly market cap
increased
from Jun. 2023 ($15,647 Mil) to Sep. 2023 ($17,596 Mil) but then
declined
from Sep. 2023 ($17,596 Mil) to Dec. 2023 ($17,404 Mil).
Fresenius SE KGaA's annual market cap
declined
from Dec. 2021 ($22,336 Mil) to Dec. 2022 ($15,748 Mil) but then
increased
from Dec. 2022 ($15,748 Mil) to Dec. 2023 ($17,404 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Fresenius SE KGaA's Enterprise Value for Today is $31,750 Mil.
Fresenius SE KGaA Market Cap Historical Data
The historical data trend for Fresenius SE KGaA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Fresenius SE KGaA's Market Cap
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Market Cap distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Market Cap falls into.
Fresenius SE KGaA Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Fresenius SE KGaA's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (OTCPK:FSNUY) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Fresenius SE KGaA Market Cap Related Terms
Thank you for viewing the detailed overview of Fresenius SE KGaA's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Fresenius SE KGaA (Fresenius SE KGaA) Business Description
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FSNUY has been successfully added to your 